Skip to main content

Diabetes Drug News

Diabetes Drugs are responsible for helping to decrease blood sugar levels so that you can try to stay in a healthier range and help avoid serious complications.

Metformin     Insulin     SGLT-2     GLP-1     DPP-4     Combo drugs     Sulfonylureas     TZDs

Information about diabetes supplies for those hit by the storms and for those who can help them
First trial next month, launch expected in 2-3 years; Dexcom CGM included; a big commitment to diabetes tech innovation from an insulin company
Seeking participants with type 2 diabetes to investigate the effects of semaglutide on heart health
Full results of DEVOTE study presented at ADA 2017 show that basal insulin Tresiba reduces risk of severe hypoglycemia by 40% (by 53% overnight), in addition to being...
FDA Approves New GLP-1 Label on Victoza to show that the medicine makes hearts healthier!
What’s new in smart pens and caps for capturing injection doses? Plus, two cool new health apps with built-in artificial intelligence
Cash-pay strips with good accuracy and co-pay programs to save money
CANVAS study presented at ADA 2017 highlights heart and kidney protection for type 2 diabetes drug Invokana, and questions persist over an increased risk of amputations
A recent trial comparing once-weekly GLP-1 agonists semaglutide and Trulicity found improved A1c and double the weight loss with semaglutide
Novo Nordisk’s newest insulin receives EMA approval; expected to launch in the first half of 2017
Research presented at ADA’s 2017 conference shows exciting advances in a host of diabetes drugs – including heart benefits, improved glucose control, lower cholesterol,...
Recall applies to sets manufactured before April 2017; Medtronic is replacing old sets that have a risk of insulin over-delivery
New apps and software updates from mySugr, Insulia, One Drop, as well as food and weight loss apps
A currently-enrolling trial is investigating a new arthritis medication along with type 2 diabetes drug Victoza, aiming to preserve insulin production in people with...
Despite neutral heart outcome study results, the FDA added a warning for those at risk of heart failure
The latest evidence on Saxenda shows that three years of treatment with the drug lowers risk for type 2 diabetes by an impressive 79%
The U.S. Food and Drug Administration (FDA) has approved the once-weekly injectable Ozempic (semaglutide) for use in type 2 diabetes.
Ketogenic (low-carb + high-fat) diet and remote coaching to “reverse” type 2 diabetes shows 60% of participants had type 2 “reversed," 94% of insulin users reduced or...
As early as 2019, the FDA could approve SGLT-2 inhibitors for adults with type 1, but some patients are already using these pills “off label”; see guidance from leading...
Read about combo drug Xultophy, Toujeo vs. Tresiba, diabetes apps, the do-it-yourself community, FreeStyle Libre real-world data, and more!

Pages